Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life.
Non-interventional Study to Assess the Impact of Myopia in Childhood and the Long-Term Complications in Adulthood on Health-Related Quality of Life (HRQoL).
Santen SAS
350 participants
Jul 29, 2025
OBSERVATIONAL
Conditions
Summary
This study aims to assess the impact of myopia in childhood and its long-term complications in adulthood on health-related Quality of Life (HRQoL), providing valuable data for cost-effectiveness models. It will gather country-specific information on healthcare resource utilization, including treatment costs, access to care, and reimbursement policies. In addition, the study will examine how myopia and its treatments affect daily activities and evaluate treatment satisfaction. No data on the efficacy of myopia treatments is collected in this study, and neither is the occurrence of adverse events.
Eligibility
Inclusion Criteria3
- Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their spherical equivalent (SER): Low myopia is from -0.5 D (inclusive) to -3.0 D (inclusive), Moderate myopia is from -3.0 D to -6.0 D (inclusive) and High myopia is <-6.0 D.
- Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment.
- Patients where myopia is a known or likely contributing factor to the complication.
Exclusion Criteria2
- Parents (or other proxy) of children aged 4 years and below.
- Patients where the complication is likely unrelated to myopia (e.g., cataract caused by diabetes) will be excluded
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Non-Intervention study
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06912802